Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05186415
PHASE1/PHASE2

Contrast Enhanced 3D Echocardiographic Quantification of Right Ventricular Volumes in Repaired CHD

Sponsor: Nemours Children's Clinic

View on ClinicalTrials.gov

Summary

We propose the novel integration of two echocardiographic technologies - three-dimensional echocardiography using semi-automated right ventricular analysis coupled with the administration of ultrasound enhancing agents - to improve the inter-rater reliability and accuracy of various measures of right ventricular size and function, compared with cardiac MRI.

Official title: Contrast Enhanced Three Dimensional Echocardiographic Quantification of Right Ventricular Volumes in Repaired Congenital Heart Disease

Key Details

Gender

All

Age Range

11 Years - Any

Study Type

INTERVENTIONAL

Enrollment

25

Start Date

2022-08-23

Completion Date

2024-06-25

Last Updated

2026-04-27

Healthy Volunteers

No

Interventions

DRUG

Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON]

The patient will receive the weight-based dose of Lumason of 0.03 mL/kg per injection, not to exceed 2.4 mL per injection per the FDA and manufacturer recommendations.

Locations (1)

Nemours Childrens Hospital

Wilmington, Delaware, United States